313 related articles for article (PubMed ID: 10890743)
41. New tools for the generation of E1- and/or E3-substituted adenoviral vectors.
Danthinne X; Werth E
Gene Ther; 2000 Jan; 7(1):80-7. PubMed ID: 10680020
[TBL] [Abstract][Full Text] [Related]
42. Conditional repression of the E2 transcription unit in E1-E3-deleted adenovirus vectors is correlated with a strong reduction in viral DNA replication and late gene expression in vitro.
Rittner K; Schultz H; Pavirani A; Mehtali M
J Virol; 1997 Apr; 71(4):3307-11. PubMed ID: 9060700
[TBL] [Abstract][Full Text] [Related]
43. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.
Murakami P; Havenga M; Fawaz F; Vogels R; Marzio G; Pungor E; Files J; Do L; Goudsmit J; McCaman M
J Virol; 2004 Jun; 78(12):6200-8. PubMed ID: 15163713
[TBL] [Abstract][Full Text] [Related]
44. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W
Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584
[TBL] [Abstract][Full Text] [Related]
45. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver.
Croyle MA; Chirmule N; Zhang Y; Wilson JM
Hum Gene Ther; 2002 Oct; 13(15):1887-900. PubMed ID: 12396620
[TBL] [Abstract][Full Text] [Related]
46. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.
Lusky M; Christ M; Rittner K; Dieterle A; Dreyer D; Mourot B; Schultz H; Stoeckel F; Pavirani A; Mehtali M
J Virol; 1998 Mar; 72(3):2022-32. PubMed ID: 9499056
[TBL] [Abstract][Full Text] [Related]
47. Characterization of human adenovirus 35 and derivation of complex vectors.
McVey D; Zuber M; Ettyreddy D; Reiter CD; Brough DE; Nabel GJ; King CR; Gall JG
Virol J; 2010 Oct; 7():276. PubMed ID: 20959004
[TBL] [Abstract][Full Text] [Related]
48. Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.
Hodges BL; Serra D; Hu H; Begy CA; Chamberlain JS; Amalfitano A
J Gene Med; 2000; 2(4):250-9. PubMed ID: 10953916
[TBL] [Abstract][Full Text] [Related]
49. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species.
Eloit M; Adam M
J Gen Virol; 1995 Jul; 76 ( Pt 7)():1583-9. PubMed ID: 9049365
[TBL] [Abstract][Full Text] [Related]
50. Adenovirus replication-competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc).
Habib NA; Mitry R; Seth P; Kuppuswamy M; Doronin K; Toth K; Krajcsi P; Tollefson AE; Wold WS
Cancer Gene Ther; 2002 Aug; 9(8):651-4. PubMed ID: 12136425
[TBL] [Abstract][Full Text] [Related]
51. Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes.
Qiao C; Li J; Skold A; Zhang X; Xiao X
J Virol; 2002 Feb; 76(4):1904-13. PubMed ID: 11799185
[TBL] [Abstract][Full Text] [Related]
52. Quantitative and in vivo activity of adenoviral-producing cells made by cotransduction of a replication-defective adenovirus and a replication-enabling plasmid.
Dion LD; Goldsmith KT; Garver RI
Cancer Gene Ther; 1996; 3(4):230-7. PubMed ID: 8853547
[TBL] [Abstract][Full Text] [Related]
53. AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle.
Lie-A-Ling M; Bakker CT; Wesseling JG; Bosma PJ
Gene Ther; 2005 Sep; 12(17):1347-52. PubMed ID: 15877046
[TBL] [Abstract][Full Text] [Related]
54. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.
Lanson NA; Friedlander PL; Schwarzenberger P; Kolls JK; Wang G
Cancer Res; 2003 Nov; 63(22):7936-41. PubMed ID: 14633724
[TBL] [Abstract][Full Text] [Related]
55. Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture.
Bangari DS; Mittal SK
Virus Res; 2004 Oct; 105(2):127-36. PubMed ID: 15351486
[TBL] [Abstract][Full Text] [Related]
56. A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus.
Gao GP; Engdahl RK; Wilson JM
Hum Gene Ther; 2000 Jan; 11(1):213-9. PubMed ID: 10646652
[TBL] [Abstract][Full Text] [Related]
57. Generation of a replication-deficient recombinant human adenovirus type 35 vector using bacteria-mediated homologous recombination.
Wu C; Lei X; Wang J; Hung T
J Virol Methods; 2011 Oct; 177(1):55-63. PubMed ID: 21763350
[TBL] [Abstract][Full Text] [Related]
58. Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein.
Doronin K; Toth K; Kuppuswamy M; Ward P; Tollefson AE; Wold WS
J Virol; 2000 Jul; 74(13):6147-55. PubMed ID: 10846098
[TBL] [Abstract][Full Text] [Related]
59. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines.
Crosby CM; Nehete P; Sastry KJ; Barry MA
J Virol; 2015 Jan; 89(1):669-75. PubMed ID: 25355873
[TBL] [Abstract][Full Text] [Related]
60. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins.
Wersto RP; Rosenthal ER; Seth PK; Eissa NT; Donahue RE
J Virol; 1998 Dec; 72(12):9491-502. PubMed ID: 9811682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
